Patent Assignment
Reel/Frame 066228/0027
Assignment of Assignor's Interest
Recorded: 2024-01-24
Pages: 14
Assignor
PHASEBIO PHARMACEUTICALS, INC.
Executed: 2023-03-30
Assignee
IMMUNOFORGE CO., LTD.
1701~1711, 58, GASAN DIGITAL 1-RO, GEUMCHEON-GU, SEOUL, 08591, KOREA, REPUBLIC OF
Covered Properties
(9)
Modified Vasoactive Intestinal Peptides
Use of Modified Vasoactive Intestinal Peptides in the Treatment of Hypertension
Modified Vasoactive Intestinal Peptides
Use of Modified Vasoactive Intestinal Peptides in the Treatment of Hypertension
Methods and Compositions for Treating Cystic Fibrosis
A Method for Administering a Sustained Release Formulation
Methods and Compositions for Treating Muscle Disease and Disorders
Methods and Compositions for Treating Muscle Disease and Disorders
Methods and Compositions for Treating Muscle Disease and Disorders
Application:
17/583,883 →
Publication:
US 2022/0288170
Related Assignments
(16)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 30, 2011
From: SADEGHI, HOMAYOUN; TURNER, ANDREW; DAGHER, SUZANNE
To: PHASBIO PHARMACEUTICALS, INC.
Reel/Frame 026530/0468 →
Assignment of Assignor's Interest
Mar 10, 2014
From: GEORGOPOULOS, LYNNE M.; ARNOLD, SUSAN
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 032388/0090 →
Assignment of Assignor's Interest
Nov 23, 2015
From: SADEGHI, HOMAYOUN; DAGHER, SUZANNE; TURNER, ANDREW
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 037117/0277 →
Assignment of Assignor's Interest
Feb 1, 2018
From: ARNOLD, SUSAN; PRIOR, CHRISTOPHER; GEORGOPOULOS, LYNNE
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 044795/0680 →
Assignment of Assignor's Interest
Apr 4, 2018
From: ARNOLD, SUSAN; BALLANCE, DAVID JAMES
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 045434/0757 →
Assignment of Assignor's Interest
Jun 15, 2018
From: GEORGOPOULOS, LYNNE M.; ARNOLD, SUSAN
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 046099/0507 →
Assignment of Assignor's Interest
Jan 2, 2020
From: GEORGOPOULOS, LYNNE; ARNOLD, SUSAN; BALLANCE, DAVID JAMES
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 051401/0327 →
Security Interest
Apr 21, 2020
From: PHASEBIO PHARMACEUTICALS, INC.
To: SILICON VALLEY BANK, AS AGENT
Reel/Frame 052456/0343 →
Assignment of Assignor's Interest
Oct 29, 2020
From: GEORGOPOULOS, LYNNE; ARNOLD, SUSAN; BALLANCE, DAVID JAMES
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 054206/0501 →
Patent and Trademark Security Agreement
Nov 12, 2020
From: PHASEBIO PHARMACEUTICALS, INC.
To: SFJ PHARMACEUTICALS X, LTD.
Reel/Frame 054401/0188 →
Security Interest
Jun 1, 2021
From: PHASEBIO PHARMACEUTICALS, INC.
To: SILICON VALLEY BANK
Reel/Frame 056405/0575 →
Assignment of Intellectual Property Security Agreement
Oct 4, 2022
From: SILICON VALLEY BANK
To: JMB CAPITAL PARTNERS LENDING, LLC
Reel/Frame 061606/0035 →
Security Interest
Oct 10, 2022
From: PHASEBIO PHARMACEUTICALS, INC.
To: JMB CAPITAL PARTNERS LENDING, LLC
Reel/Frame 061367/0674 →
Security Interest
Oct 31, 2022
From: PHASEBIO PHARMACEUTICALS, INC.
To: JMB CAPITAL PARTNERS LENDING, LLC
Reel/Frame 061601/0001 →
Release of Security Interest
Jan 13, 2023
From: JMB CAPITAL PARTNERS LENDING, LLC
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 062376/0850 →
Assignment of Assignor's Interest
Nov 22, 2023
From: GEORGOPOULOS, LYNNE; ARNOLD, SUSAN; BALLANCE, DAVID JAMES
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 065650/0198 →